Top Markets
Coin of the day
Q BioMed Inc. Q BioMed Inc.

Q BioMed Inc.

QBIO
Rangering i aksjer #41615
Q BioMed Inc. functions as a biomedical accelerator and developer, actively... Q BioMed Inc. functions as a biomedical accelerator and developer, actively licensing, acquiring, and supplying resources to firms within the life sciences and healthcare sectors. Its commercial portfolio includes Metastron (Strontium Chloride SR89), a radiopharmaceutical designed to alleviate pain associated with metastatic bone cancer. Additionally, Q BioMed is advancing a pipeline of therapeutic candidates, including Man-01, a pre-clinical compound aimed at primary open-angle glaucoma; QBM-001, intended for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, which targets liver cancer. The company also collaborates with Mannin Research Inc. on the development of treatments for conditions such as acute respiratory distress syndrome, glaucoma, and various kidney diseases. Incorporated in New York, New York, in 2013, the entity was initially named ISMO Tech Solutions, Inc. before adopting its current name, Q BioMed Inc., in July 2015.
Aksjekurs
$0.0001
Sist synkronisert: 2026-04-02
Markedsverdi
$14.51K
Endring (1 dag)
0.00%
Endring (1 år)
9,900.00%
Land
US
Handel Q BioMed Inc. (QBIO)

Kategori

Historikk for aksjesplitt for Q BioMed Inc. (QBIO)
Aksjen Q BioMed Inc. (symbol: QBIO) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 13, 2026.
Én QBIO-aksje kjøpt før Aug 13, 2026 tilsvarer i dag 0 QBIO-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR